Skip to main content
OpenTrials

Clinical trial condition

Sleep Disorders, Intrinsic

Explore clinical trials studying Sleep Disorders, Intrinsic. Study availability and eligibility vary by location and protocol.

4,484 public trials 661 recruiting studies
Refine in advanced search Browse all conditions

Sleep Disorders, Intrinsic trial results

Recruiting

A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

NCT07540897

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +8 more
Locations
  • Alkermes Investigational Site Miami, Florida, United States
  • Alkermes Investigational Site Winter Park, Florida, United States
  • Alkermes Investigational Site Atlanta, Georgia, United States
  • Alkermes Investigational Site Macon, Georgia, United States
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

NCT07502443

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Mental Disorders, +7 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 19 locations
View Trial Details
Recruiting

A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

NCT07500090

Conditions
Disorders of Excessive Somnolence, Dyssomnias, Fatigue, +7 more
Locations
  • Sleep Disorders Center of Alabama Birmingham, Alabama, United States
  • Stanford Center for Sleep Medicine Redwood City, California, United States
  • Santa Monica Clinical Trials Santa Monica, California, United States
  • Alpine Clinical Research Center, Inc. Boulder, Colorado, United States
View all 22 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

NCT07455383

Conditions
Cataplexy, Disorders of Excessive Somnolence, Dyssomnias, +10 more
Locations
  • Alkermes Investigational Site Cullman, Alabama, United States
  • Alkermes Investigational Site Los Angeles, California, United States
  • Alkermes Investigational Site Boulder, Colorado, United States
  • Alkermes Investigational Site Brandon, Florida, United States
View all 22 locations
View Trial Details

Related conditions